Apoptosis in bone physiology and disease

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 3, 1997, Pages 132-137

  Hughes, David E ^a   Boyce, Brendan F ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ANTIESTROGEN; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN RECEPTOR; CALCITRIOL; COLONY STIMULATING FACTOR 1; CORTICOSTEROID; CYTOKINE; ESTROGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; PARATHYROID HORMONE; SEX HORMONE; TAMOXIFEN; TARTARIC ACID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BONE DISEASE; BONE REMODELING; CELL DEATH; DRUG THERAPY; ETIOLOGY; GROWTH PLATE; HUMAN; HYPERPARATHYROIDISM; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PAGET BONE DISEASE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0030722948     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.3.132     Document Type: Review

References (53)

1. Frost HM. The laws of bone structure. Springfield: Charles C Thomas, 1964.
2. Baron R, Vignery A, Horowitz M. Lymphocytes, macrophages and the regulation of hone remodelling. In: Peck WA, ed. Bone and mineral research 2. Amsterdam: Elsevier, 1983:175-245.
3. Roach HI, Erenpreisa J, Aigner T. Osteogenic differentiation of hypertrophic chondrocytes involves asymmetric cell divisions and apoptosis. J Cell Biol 1995;131:483-94.
4. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993;74:777-9.
5. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, et al. Apoptosis: molecular regulation of cell death. Eur J Biochem 1996;236:1-26.
6. Mundy GR, Roodman GD. Osteoclast ontogeny and function. In: Peck W, ed. Bone and mineral research 1. Amsterdam: Elsevier, 1987:209-80
7. McSheehy PMJ, Chambers TJ. Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone. Endocrinology 1986;118:824-8.
8. Thomson BM, Saklatvala J, Chambers TJ. Osteoblasts mediate interleukin-1 responsiveness of bone resorption by rat osteoclasts. J Exp Med 1986;164:104-12.
9. Arey LB. The origin, growth and fate of osteoclasts and their relation to bone resorption. American Journal of Anatomy 1920;26:315-45.
10. Liu C-C, Rader JI, Gruber H, Baylink DJ. Acute reduction in osteoclast number during bone repletion. Metab Bone Dis Rel Res 1982;4:201-9.
11. Fuller K, Owens JM, Jagger CJ, Wilson A, Moss R, Chambers TJ. Macrophage colony-stimulating factor stimulates survival and chemotactic behaviour in isolated osteoclasts. J Exp Med 1993;178:1733-44.
12. Boyce BF, Windle JJ, Reddy SV, Wright K, Leach RJ, Roodman GD. Targeting SV-40 T antigen to the osteoclast in transgenic mice causes osteopetrosis, transformation and apoptosis of osteoclasts [abstract]. J Bone Miner Res 1993; 8(Suppl):S118.
13. Boyce BF, Wright K, Reddy SV, Koop BA, Story B, Devlin R, et al. Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts. Endocrinology 1995;136:5751-9.
14. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
15. Boyce BF, Aufdemorte TB, Garrett IR, Yates AJP, Mundy GR. Effects of interleukin-1 on bone turnover in normal mice. Endocrinology 1989;125:1142-50.
16. Wright KR, Hughes DE, Guise TA, Boyle IT, Devlin R, Windle J, et al. Osteoclasts undergo apoptosis at the interface between resorption and formation in bone remodelling units [abstract]. J Bone Miner Res 1994;9(Suppl): S174.
17. Wright KR, McMillan PJ, Hughes DE, Boyce BF. Calcium deficiency repletion in rats as an in vivo model for the study of osteoclast apoptosis. J Bone Miner Res 1995;10(Suppl): S328.
18. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982;34:285-90.
19. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 1995;10:1478-87.
20. Garrett IR, Mundy GR. Relationship between interleukin-1 and prostaglandins in resorbing neonatal calvaria. J Bone Miner Res 1989;4:789-94.
21. Jimi E, Shuto T, Koga T. Macrophage colony-stimulating factor and interleukin-1a maintain the survival of osteoclast-like cells. Endocrinology 1995;136:808-11.
22. Hughes DE, Wright KR, Sasaki A, Yoneda T, Uy H, Roodman GD, et al. Bisphosphonates induce osteoclast apoptosis in vivo and in vitro, but calcitonin does not [abstract]. J Bone Miner Res 1994;9(Suppl):S347.
23. Selander KS, Monkkonen J, Karhukorpi E-K, Harkonene P, Hannuniemi R, Vaananen HK. Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol Pharmacol 1996;50:1127-38.
24. Kameda T, Ishikawa H, Tsutsui T. Detection and characterization of apoptosis in osteoclasts in vitro. Biochem Biophys Res Commun 1995;207:753-60.
25. Lutton JD, Moonga BS, Dempster DW. Osteoclast demise in the rat: physiological versus degenerative cell death. Exp Physiol 1996;81:251-60.
26. Chambers TM, Magnus CJ. Calcitonin alters behaviour of isolated osteoclasts. J Pathol 1982;136:27-39.
27. Hughes DE, Dai, A, Tiffee JC, Li HH, Mundy GR, Boyce BF. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nature Medicine 1996;2:1132-6.
28. Arnett TR, Lindsay R, Kilb JM, Moonga BS, Spowage M, Dempster DW. Selective toxic effects of tamoxifen on osteoclasts: Comparison with the effects of oestrogen. J Endocrinol 1996;149:503-8.
29. Horowitz MC. Cytokines and estrogen in bone; anti-osteoporotic effects. Science 1993;260:626-7.
30. Pacifici R. Is there a causal role for IL-1 in postmenopausal bone loss? Calcif Tissue Int 1992;50:295-9.
31. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257: 88-91.
32. Hughes DE, Wright KR, Mundy GR, Boyce BF. TGFB1 induces osteoclast apoptosis in vitro [abstract]. J Bone Miner Res 1994;9(Suppl):S138.
33. Shevde NK, Pike JW. Estrogen modulates the recruitment of myelopoietic cell progenitors through a stromal cell-independent mechanism involving apoptosis. Blood 1996; 87:2683-92.
34. Grasser WA, Mansolf AL, Pirie CM, Cameron KO, Toler SM, Rosati RL, et al. CP-336, 156 and estrogen identically inhibit osteoclastogenesis in rat bone marrow cultures through an apoptotic mechanism [abstract]. J Bone Miner Res 1996;11(Suppl):S397.
35. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-8.
36. Hughes DE, Wright KR, Mundy GR, Boyce BF. Association of osteoclast apoptosis with loss of adhesion [abstract]. J Bone Miner Res 1995;10(Suppl):S326.
37. Fleisch H. Bisphosphonates in bone disease: From the laboratory to the patient. 2nd edn. New York: Parthenon Publishing Group, 1995.
38. Liu C-C, Howard GA. Bone-cell changes in estrogen-induced bone-mass increase in mice: Dissociation of osteoclasts from bone surfaces. Anat Rec 1991;229:240-50.
39. Elmardi AS, Katchburian MV, Katchburian E. Electron microscopy of developing calvaria reveals images that suggest that osteoclasts engulf and destroy osteocytes during bone resorption. Calcif Tissue Int 1990;46:239-45.
40. Noble BS, Stevens H, Reeve J, Loveridgc N. Apoptosis in normal and pathological human bone [abstract]. J Bone Miner Res 1995;10(Suppl):S217.
41. Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies oestrogen withdrawal in human bone [abstract]. J Bone Miner Res 1996; 11(Suppl):S129.
42. Wong SYP, Evans RA, Needs C, Dunstan CR, Hills E, Garvan J. The pathogenesis of osteoarthritis of the hip. Evidence for primary osteocyte death. Clin Orthop Rel Res 1987;214:305-12.
43. Jilka RL, Weinstein RS, Bellido T, Miller FL, Smith C, Parfitt AM, et al. Demonstration of programmed cell death (apoptosis) in osteoblasts: evidence for modulation of this process by growth factors and cytokines [abstract]. J Bone Miner Res 1996;11(Suppl):S144.
44. Wright KR, Story B, Hughes DE, Windle J, Reddy S, Roodman GD, et al. Standard morphology is more sensitive than TUNEL for identification of apoptosis in osteoclasts [abstract]. J Bone Miner Res 1995;10(Suppl):S324.
45. 2 suppresses apoptosis in two rat periosteal cell lines via a cAMP-dependent pathway [abstract]. J Bone Miner Res 1996;11(Suppl):S143.
46. Nuttall ME, Gowen M. Human osteosarcoma (HOS TE-85) cells undergo an apoptotic process that is inhibited by IGF-1 [abstract]. J Bone Miner Res 1996;11(Suppl): S375.
47. Watanabe H, MacKay C, Kislauskis E, Mason-Savas A, Marks SC Jr. The cytoskeleton, cell attachment and survival of osteoblasts in osteopetrotic (tl) rats [abstract]. J Bone Miner Res 1996;11(Suppl);S172.
48. Henderson JE, Naski M, Ornitz DM, Goltzman D, Karaplis AC. Expression of FGFR3 carrying the G380R achondroplasia mutation in rodent chondrocytes: effects on proliferation, differentiation and apoptosis (abstract). J Bone Miner Res 1996;11(Suppl);S103.
49. Dunstan CR, Evans RA, Hills E, Wong SY, Higgs RJ. Bone death in hip fracture in the elderly. Calcif Tissue Int 1990;47:270-5.
50. Scholz RB, Kabisch H, Weber B, Roser K, Delling G, Winkler K. Studies of the RB1 gene and the p53 gene in human osteosarcomas. Paediatric Hematol Oncol 1992;9:125-37.
51. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, et al. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 1994;9:1877-83.
52. Miller CW, Aslo A, Won A, Tan M, Lampkin B, Koeffler HP. Alterations of the p53, Rb and MDM2 genes in osteosarcoma. J Cancer Res Clin Oncol 1996;122:559-65.
53. Almasan A, Yin Y, Kelly RE, Lee EY, Bradley A, Li W, et al. Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 1995;92:5436-40.